Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Live Webinar: China in the fast lane: How to play and win in the world’s hottest emerging market

    April 9, 2019 | China, Pharma, webinar 

    Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST

    China has always been believed to be the land of promise for multinational pharmaceutical companies. However, up until recently many organisations have struggled to see a return on their investments. That may all be set to change though.

    The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, opening up a whole new world of opportunities for the pharmaceutical industry.

    Register now for our next live webinar in which emerging markets experts Marc Yates and Helen Ansell will explore China’s evolving healthcare environment, highlight the key changes affecting pharma and show you how to  build the market understanding required to launch a brand effectively in this exciting region.

    When: Tuesday 16th April 2019 
    Time: 10:00 EST/ 15:00 GMT / 16:00 CEST

    Register now to secure your place »

    China’s key growth factors:

    Fast track approvals: So far, over 180 foreign pharma products have been granted priority review and will likely hit the market within the next few years.

    From an ability to pay to willingness to pay: By 2022 more than half of the urban population will be defined as upper middle class and as incomes rise so does willingness to pay for quality healthcare.

    Shifting disease patterns: Diseases of affluence are also on the rise and the benefits of urban life have resulted in an aging population and an explosion in age-related conditions.

    What are the key takeaways in this webinar? 

    1. China 101 
    An overview of the healthcare environment in China

    2. What’s changed?
    The key opportunities under China’s 2020 healthcare reform

    3. Where to play? How to win?
    Design an effective marketing strategy with insights that prepare you for optimal success.

    4. Gain answers to your key questions
    Start the conversation by submitting your questions in advance when you register.

    Register now to secure your place »
    If you are unable to attend but would like to view the recording, register now and we will send you a unique link to download it as soon as it is ready.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Webcast: Leveraging the ASEAN opportunities

    Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

    Webcast: Biosimilars: Friend or Foe to Healthcare?

    Understanding the opportunities for biosimilars and the threats to innovator biologics

    Webinar: Understanding the patient journey in China

    The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

    Webinar: Capturing “in-the-moment” patient and physician insights

    Utilising the benefits of mobile technology

    Webinar: Observational Research

    Presenting a window on the world of your customer

    Webinar: The Brazil Conundrum

    Conducting research in one of the world's largest pharma markets

    Webinar: Demand calibration: What’s inside the black box?

    The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

    Free Thinking: Behavioural economics

    Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

    Article: The Colombia Conundrum

    Published in eye for pharma 30 January by Marc Yates

    Ageing in China: The Implications for Healthcare

    Published in eye for pharma 12 December by Marc Yates